| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/06/2007 | US20070280884 Insect poison allergens with reduced IgE reactivity and method for producing the same |
| 12/06/2007 | US20070280879 Therapeutic Use Of Rm1 Antigen |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653288A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
| 12/05/2007 | EP1862546A1 Enhanced virus-mediated dna transfer |
| 12/05/2007 | EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 12/05/2007 | EP1862472A2 Chlamydia protein, gene sequence and uses thereof |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862450A2 Novel compounds |
| 12/05/2007 | EP1862444A2 Ether compounds, compositions, and uses thereof |
| 12/05/2007 | EP1862173A1 Promoter of regeneration of pancreatic cell, and promoter of insulin production in pancreatic cell |
| 12/05/2007 | EP1862165A2 Prevention and treatment of androgen-deprivation induced hot flashes |
| 12/05/2007 | EP1862164A2 Dry powder for inhalation |
| 12/05/2007 | EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders |
| 12/05/2007 | EP1433479B1 Appetite-stimulating agents and remedies for anorexia |
| 12/05/2007 | EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |
| 12/05/2007 | EP1362844B1 Benzylamine analogue |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | EP1263752B1 Lpa receptor agonists and antagonists and methods of use |
| 12/05/2007 | EP1208085B1 Benzanilides as potassium channel openers |
| 12/05/2007 | EP1169294B1 Pharmaceutical compounds |
| 12/05/2007 | EP1148872B1 Stable pharmaceutical formulation comprising pravastatin or atorvastatin |
| 12/05/2007 | EP1073418B1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 12/05/2007 | EP0931149B1 A novel haemopoietin receptor and genetic sequences encoding same |
| 12/05/2007 | CN101083992A Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 12/05/2007 | CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 12/05/2007 | CN101081281A Anti-fatigue resistibility capsules for improving body immunity and method for making same |
| 12/05/2007 | CN100352930C Vaccines immunotherapeutics and method for using the same |
| 12/05/2007 | CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
| 12/05/2007 | CN100352817C Pyridinoylpiperidines as 5-HTLF agonists |
| 12/05/2007 | CN100352816C Nociceptin analogs |
| 12/05/2007 | CN100352810C Fumagillol derivatives and processes for preparing the same |
| 12/05/2007 | CN100352809C Aminophenylbenzothiazole compounds |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 12/05/2007 | CN100352804C 酰胺衍生物 Amide derivatives |
| 12/05/2007 | CN100352510C Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 12/05/2007 | CN100352506C Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents |
| 12/05/2007 | CN100352503C Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 12/05/2007 | CN100352499C High mannose proteins and method of making mannose proteins |
| 12/05/2007 | CN100352497C Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 12/05/2007 | CN100352495C Stabilized pharmaceutical composition in lyophilized form |
| 12/05/2007 | CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 12/05/2007 | CN100352448C Methods and compositions for the prevention of tolerance to medications |
| 12/05/2007 | CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 12/05/2007 | CN100352441C Combination therapy for the treatment of cancer |
| 12/05/2007 | CN100352437C Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 12/04/2007 | US7304174 CaSR antagonist |
| 12/04/2007 | US7304167 Biphenylcarboxamides useful as lipid lowering agents |
| 12/04/2007 | US7304166 (2S,4S)-2-Cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine benzenesulfonate; dipeptidyl peptidase IV inhibitors with high-purity uniform crystal form and excellent solid-state stability |
| 12/04/2007 | US7304158 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide |
| 12/04/2007 | US7304144 Antibodies binding to human TSLP Polypeptides |
| 12/04/2007 | US7304091 Statin-like compounds |
| 12/04/2007 | US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice |
| 12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
| 12/04/2007 | US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents |
| 12/04/2007 | US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction |
| 12/04/2007 | US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders |
| 12/04/2007 | US7304077 Asthma, rhinitis therapy |
| 12/04/2007 | US7304072 Spiro compounds |
| 12/04/2007 | US7304062 Peroxisome proliferator activated receptor alpha agonists |
| 12/04/2007 | US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/04/2007 | US7304059 Substituted quinazolin-4-ylamine analogues |
| 12/04/2007 | US7304056 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease |
| 12/04/2007 | US7304055 Succinoylamino lactams as inhibitors of Aβ protein production |
| 12/04/2007 | US7304053 Glycoprotein-mediated MDR |
| 12/04/2007 | US7304052 Irritable bowel syndrome; gastrointestinal disorders |
| 12/04/2007 | US7304049 Succinamides N-monosubstituted with with a dibenzo[b,e]azepinone group that inhibit the production of A beta-peptide, acting to prevent the formation of neurological deposits of amyloid protein; treating Alzheimer's Disease |
| 12/04/2007 | US7304048 For use as anti-inflammatory agents |
| 12/04/2007 | US7304037 Cytostatic conjugates with integrin ligands |
| 12/04/2007 | US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 12/04/2007 | US7304032 CD-10 activated prodrug compounds |
| 12/04/2007 | US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms |
| 12/04/2007 | US7303896 Nucleic acid encoding novel type-1 cytokine receptor GLM-R |
| 12/04/2007 | US7303890 Proteins, genes encoding them and method of using the same |
| 12/04/2007 | US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | US7303758 From a two-layered polymeric matrix including incompatible polymers, the top layer controls elution rate of said drugs; e.g. fluoropolymer layer covered with a polyacrylate top layer; stents, anastomotic devices |
| 12/04/2007 | CA2424964C Nitrogen-containing 5-membered ring compound |
| 12/04/2007 | CA2346555C Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 12/04/2007 | CA2345622C Tricyclic .delta.3-piperidines as .alpha.2-antagonists |
| 12/04/2007 | CA2337800C Farnesyl protein transferase inhibitors for treating arthropathies |
| 12/04/2007 | CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 12/04/2007 | CA2255891C Compositions and methods for treating or preventing diseases of body passageways |
| 12/04/2007 | CA2233315C Pharmaceutical compositions containing hydroximic acid derivatives |
| 12/04/2007 | CA2212205C Use of xanthine derivatives for the modulation of apoptosis |
| 12/04/2007 | CA2210533C Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors |
| 12/04/2007 | CA2157506C Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 11/29/2007 | WO2007136989A2 Compounds and methods for modulating expression of dgat2 |
| 11/29/2007 | WO2007136988A2 Compounds and methods for modulating expression of gccr |
| 11/29/2007 | WO2007136633A2 Gel-formulations of hydrophobic photosensitizers for mucosal applications |
| 11/29/2007 | WO2007136125A1 Compound having heterocyclic ring and use thereof |
| 11/29/2007 | WO2007136085A1 Spiro tetracyclic compound |
| 11/29/2007 | WO2007135970A1 Heterocyclic type cinnamide derivative |
| 11/29/2007 | WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy |
| 11/29/2007 | WO2007135774A1 Oral liquid preparation composition containing herbal medicine |